EOM Pharmaceutical (IMUC) News Today $0.09 -0.01 (-5.84%) As of 08/8/2025 03:30 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartSEC FilingsShort InterestBuy This Stock IMUC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Q32 Bio Inc. R (DB0.BE)January 15, 2025 | finance.yahoo.comImmunoCellular Therapeutics, Ltd. (IMUC)January 5, 2024 | uk.finance.yahoo.comEOM Pharmaceutical Holdings Inc.December 29, 2023 | wsj.comEOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613November 7, 2023 | finance.yahoo.comIZERVAY™ (avacincaptad pegol intravitreal solution) Monthly or Every Other Month Reduced Geographic Atrophy Lesion Growth Through 2 YearsNovember 4, 2023 | markets.businessinsider.comImmunoGen (IMGN) Q3 Earnings Beat, Elahere Drives RevenuesNovember 3, 2023 | msn.comOramed Pharmaceuticals Inc ORMPNovember 1, 2023 | morningstar.comMAnalyst Ratings for Olema PharmaceuticalsOctober 11, 2023 | markets.businessinsider.comEOM Pharmaceutical Holdings Announces Topline Results of its COVID-19 Clinical Trial of EOM613 in BrazilSeptember 6, 2023 | finance.yahoo.comQ2 2023 PAVmed Inc Earnings CallAugust 17, 2023 | uk.finance.yahoo.comEOM Pharmaceuticals shelves plans to uplist shares, raise $15MAugust 3, 2023 | msn.comAcumen Pharmaceuticals Announces Proposed Public Offering of Common StockJuly 17, 2023 | benzinga.comAmneal Pharmaceuticals: FDA Requests Additional Information on IPX203 IngredientJuly 3, 2023 | marketwatch.comAmneal Pharmaceuticals Gets FDA Approval for Injectable Tumor TreatmentJune 14, 2023 | marketwatch.comTrade commission fights Amgen's $28B purchase of Horizon TherapeuticsMay 16, 2023 | msn.comPharma CEOs to testify in U.S. Senate hearing on insulin pricesMay 10, 2023 | msn.com8-K: Acumen Pharmaceuticals, Inc.May 10, 2023 | marketwatch.comOlema Pharmaceuticals GAAP EPS of -$0.70 misses by $0.04May 9, 2023 | msn.comOliX Pharmaceuticals Inc (226950)May 9, 2023 | investing.comUSFDA gives final nod to Alembic Pharmaceuticals’ Glaucoma drugMarch 30, 2023 | msn.comU.S. Supreme Court mulls Amgen bid to revive cholesterol drug patentsMarch 27, 2023 | reuters.comRegeneron Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gainsMarch 13, 2023 | marketwatch.comEOM Pharmaceuticals Holdings, Inc. (IMUC)March 11, 2023 | finance.yahoo.comIonis Pharmaceuticals, Inc. (IONS) Q4 2022 Earnings Call TranscriptFebruary 24, 2023 | seekingalpha.comAltruBio Hosting Research & Development Update on Immune Checkpoint Enhancer Platform for T Cell Mediated Immunological DiseasesDecember 8, 2022 | technews.tmcnet.comAlaunos Therapeutics Shares Drop 24% After Public Offering PricesNovember 29, 2022 | marketwatch.comInVivo Therapeutics Adds to Surge After Hours, Recently at $10.85October 6, 2022 | marketwatch.comImunon Appoints James E. Dentzer to its Board of DirectorsOctober 3, 2022 | benzinga.comSeres Therapeutics Inc MCRB Stock QuoteSeptember 21, 2022 | morningstar.comMImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Guggenheim Nantucket Therapeutics ConferenceSeptember 14, 2022 | benzinga.comImmunoCellular Therapeutics LtdSeptember 11, 2022 | reuters.comEOM Pharmaceutical Files For $25 Million IPO Uplisting To NasdaqJune 28, 2022 | seekingalpha.comEOM Pharmaceuticals files to uplist to NasdaqJune 24, 2022 | seekingalpha.comEOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger AgreementDecember 2, 2021 | finance.yahoo.com Get EOM Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for IMUC and its competitors with MarketBeat's FREE daily newsletter. Email Address IMUC Media Mentions By Week IMUC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMUC News Sentiment▼0.000.43▲Average Medical News Sentiment IMUC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMUC Articles This Week▼00▲IMUC Articles Average Week Get EOM Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for IMUC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALGS News TELO News OSTX News PRLD News ATNM News ATHE News XCUR News KALA News IPSC News VTVT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:IMUC) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EOM Pharmaceutical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share EOM Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMUC Stock Alerts